HK Stock Market Move | LIVZON PHARMA (01513) Surges Over 10% on Generous Dividend Payout and Formulation of Three-Year Shareholder Return Plan

LIVZON PHARMA (01513) surged over 10%, up 10.34% as of press time to HK$22.84, with turnover of HK$61.4877 million. On the news front, LIVZON PHARMA announced a proposed cash dividend of RMB12.39 per 10 shares (tax inclusive) to all shareholders, with total cash dividends expected to be RMB1.10 billion. Notably, the company has also formulated the "Shareholder Return Plan for the Next Three Years (20262028)," specifying that, subject to meeting cash dividend conditions, the total annual cash dividend amount shall in principle be no less than 90% of the distributable profit realized in the current year, and the total annual cash dividend amount shall in principle be no less than RMB2 billion (tax inclusive). LIVZON PHARMA's third-quarter report shows that in the first three quarters of 2026, operating revenue was RMB7.319 billion, down 19.71% year on year; net profit attributable to shareholders of the listed company was RMB1.288 billion, down 26.57% year on year. In the third quarter alone, main operating revenue was RMB2.32 billion, down 18.44% year on year; net profit attributable to the parent company in the quarter was RMB356 million, down 24.76% year on year.